Drug intelligence / Profile preview

articaine + tramadol

Development stage
Unknown
Lead developer
Marmara University
Modality
Small Molecules
Administration
Local
01

Overview

Articaine + tramadol is a combination therapy being investigated for its efficacy in managing pain associated with the surgical extraction of third molars. Articaine is a local anesthetic of the amide type that functions as a sodium channel blocker, inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses. Tramadol is a centrally acting synthetic opioid analgesic that possesses a dual mechanism of action: it acts as a mu-opioid receptor agonist and also inhibits the neuronal reuptake of serotonin and norepinephrine. The combination is typically administered via an inferior alveolar nerve block to enhance the depth and duration of anesthesia while providing superior postoperative analgesia compared to local anesthetic alone. This specific research and clinical evaluation are led by Marmara University.

Other names
articaine hydrochloride + tramadol hydrochloridetramadol combined with local anesthesiaarticaine + tramadol hydrochloride
02

Targets

SERT (Sodium-dependent serotonin transporter)MOR (Mu opioid receptor)NET (Norepinephrine Transporter)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on articaine + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on articaine + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call